1,917
Views
53
CrossRef citations to date
0
Altmetric
Review

Pathophysiology, assessment and management of multiple sclerosis fatigue: an update

, , &
Pages 373-379 | Received 29 Apr 2016, Accepted 10 Oct 2016, Published online: 21 Oct 2016

References

  • Noseworthy JH, Lucchinetti C, Rodriguez M, et al. Multiple sclerosis. N Engl J Med. 2000;343(13):938–952.
  • Trapp BD, Peterson J, Ransohoff RM, et al. Axonal transection in the lesions of multiple sclerosis. N Engl J Med. 1998;338(5):278–285.
  • Pugliatti M, Rosati G, Carton H, et al. The epidemiology of multiple sclerosis in Europe. Eur J Neurol. 2006;13:700–722.
  • Fisk JD, Pontefract A, Ritvo PG, et al. The impact of fatigue on patients with multiple sclerosis. Can J Neurol Sci. 1994;21(1):9–14.
  • Mills RJ, Young CA. A medical definition of fatigue in multiple sclerosis. QJM. 2008;101:49–60.
  • Gandevia SC, Allen GM, Butler GE, et al. Supraspinal factors in human muscle fatigue: evidence for suboptimal output from the motor cortex. J Physiol. 1996;490:529–536.
  • Leocani L, Colombo B, Magnani G, et al. Fatigue in multiple sclerosis is associated with abnormal cortical activation to voluntary movement-EEG evidence. Neuroimage. 2001;13:1186–1192.
  • Thickbroom GW, Sacco P, Kermode AG, et al. Central motor drive and perception of effort during fatigue in multiple sclerosis. J Neurol. 2006;253:1048–1053.
  • Perretti A, Balbi P, Orefice G, et al. Post-exercise facilitation and depression of motor evoked potentials to transcranial magnetic stimulation: a study in multiple sclerosis. Clin Neurophysiol. 2004;115:2128–2133.
  • Liepert J, Mingers D, Heesen C, et al. Motor cortex excitability and fatigue in multiple sclerosis: a transcranial magnetic stimulation study. Mult Scler. 2005;11:316–321.
  • Roelcke U, Kappos L, Lechner-Scott J, et al. Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue: a 18F-fluorodeoxyglucosepositronemissiontomography study. Neurology. 1997;48(6):1566–1571.
  • Filippi M, Rocca MA, Colombo B, et al. Functional magnetic resonance imaging correlates of fatigue in multiple sclerosis. Neuroimage. 2002;15(3):559–567.
  • Tartaglia MC, Narayanan S, Francis SJ, et al. The relationship between diffuse axonal damage and fatigue in multiple sclerosis. Arch Neurol. 2004;61(2):201–207.
  • Derache N, Grassiot B, Mezebge F, et al. Fatigue is associated with metabolic and density alterations of cortical and deep gray matter in relapsing-remitting-multiple sclerosis patients at the earlier stage of the disease: a PET/MR study. Mult Scler Relat Disord. 2013;2:362–369.
  • Tedeschi G, Dinacci D, Lavorgna L, et al. Correlation between fatigue and brain atrophy and lesion load in multiple sclerosis patients independent of disability. J Neurol Sci. 2007;263(1–2):15–19.
  • Pellicano C, Gallo A, Li X, et al. Relationship of cortical atrophy to fatigue in patients with multiple sclerosis. Arch Neurol. 2010;67(4):447–453
  • Marrie RA, Fisher E, Miller DM, et al. Association of fatigue and brain atrophy in multiple sclerosis. J Neurol Sci. 2005;228(2):161–166.
  • Salamone JD, Correa M, Farrar A, et al. Effort-related functions of nucleus accumbens dopamine and associated forebrain circuits. Psychopharmacology (Berl). 2007;191(3):461–482.
  • Rocca MA, Parisi L, Pagani E, et al. Regional but not global brain damage contributes to fatigue in multiple sclerosis. Radiology. 2014;273:511–520.
  • Leocani L, Colombo B, Comi G. Phsysiopathology of fatigue in multiple sclerosis. Neurol Sci. 2008;39:S241–S243.
  • Heesen C, Nawrath L, Reich C, et al. Fatigue in multiple sclerosis: an example of cytokine mediated sickness behaviour? J Neurol Neurosurg Psychiatry. 2006;77(1):34–39.
  • Brkic S, Tomic S, Maric D, et al. Lipid peroxidation is elevated in female patients with chronic fatigue syndrome. Med Sci Monit. 2010;16:CR628–CR632.
  • Dudman NP, Wilcken DE, Stocker R. Circulating lipid hydroperoxide levels in human hyperhomocysteinemia. Relevance to development of arteriosclerosis. Arterioscler Thromb. 1993;13:512–516.
  • Morris G, Berk M, Galecki P, et al. The neuro-immune pathophysiology of central and peripheral fatigue in systemic immune-inflammatory and neuro-immune diseases. Mol Neurobiol. 2016 Mar;53(2):1195–1219.
  • Gottschalk M, Kümpfel T, Flachenecker P, et al. Fatigue and regulation of the hypothalamo-pituitary-adrenal axis in multiple sclerosis. Arch Neurol. 2005;62(2):277–280.
  • Téllez N, Comabella M, Julià E, et al. Fatigue in progressive multiple sclerosis is associated with low levels of dehydroepiandrosterone. Mult Scler. 2006;12(4):487–494.
  • Perez-Aso M, Feig JL, Mediero A, et al. Adenosine A2A receptor and TNFalpha regulate the circadian machinery of the human monocytic THP-1 cells. Inflammation. 2013;36:152–162.
  • Yoshida K, Hashimoto T, Sakai Y, et al. Involvement of the circadian rhythm and inflammatory cytokines in the pathogenesis of rheumatoid arthritis. J Immunol Res. 2014;2014:282495.
  • Noronha MJ, Vas CJ, Aziz H. Autonomic dysfunction (sweating responses) in multiple sclerosis. J Neurol Neurosurg Psychiatry. 1968;31(1):19–22.
  • Leavitt VM, De Meo E, Riccitelli G, et al. Elevated body temperature is linked to fatigue in an Italian sample of relapsing-remitting multiple sclerosis patients. J Neurol. 2015;262(11):2440–2442.
  • Malkki H. Multiple sclerosis: dehydration might contribute to fatigue in MS. Nat Rev Neurol. 2016 Sep 2;12:555-555. [ Epub 2015 Jul 30].
  • Bakshi R, Shaikh ZA, Miletich R, et al. Fatigue in multiple sclerosis and its relationship to depression and neurologic disability,”. Mult Scler. 2000;6(3):181–185.
  • Comi G, Leocani L, Rossi P, et al. Physiopathology and treatment of fatigue in multiple sclerosis. J Neurol. 2001;248(3):174–179.
  • Krupp LB, LaRocca NG, Muir-Nash J, et al. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989;46(10):1121–1123.
  • Dittner AJ, Wessely SC, Brown RG. The assessment of fatigue: a practical guide for clinicians and researchers. J Psychosom Res. 2004;56(2):157–170.
  • LaChapelle DL, Finlayson MA. An evaluation of subjective and objective measures of fatigue in patients with brain injury and healthy controls. Brain Inj. 1998;12(8):649–659.
  • Amtmann D, Bamer AM, Noonan V, et al. Comparison of the psychometric properties of two fatigue scales in multiple sclerosis. Rehabil Psychol. 2012;57(2):159–166.
  • Kalron A. The correlation between symptomatic fatigue to definite measures of gait in people with multiple sclerosis. Gait Posture. 2016;44:178–183.
  • Heine M, van de Port I, Rietberg MB, et al. Exercise therapy for fatigue in multiple sclerosis. Cochrane Database Syst Rev. 2015;11(9):CD009956.
  • Elbers RG, Rietberg MB, van Wegen EE, et al. Self-report fatigue questionnaires in multiple sclerosis, Parkinson’s disease and stroke: a systematic review of measurement properties. Qual Life Res. 2012;21(6):925–944.
  • Rietberg MB, Van Wegen EE, Kwakkel G. Measuring fatigue in patients with multiple sclerosis: reproducibility, responsiveness and concurrent validity of three Dutch self-report questionnaires. Disabil Rehabil. 2010;32(22):1870–1876.
  • Mills R, Young C, Nicholas R, et al. Rasch analysis of the Fatigue Severity Scale in multiple sclerosis. Mult Scler. 2009;15(1):81–87.
  • Mills RJ, Young CA, Pallant JF, et al. Rasch analysis of the Modified Fatigue Impact Scale (MFIS) in multiple sclerosis. J Neurol Neurosurg Psychiatry. 2010;81(9):1049–1051.
  • Learmonth YC, Dlugonski D, Pilutti LA, et al. Psychometric properties of the fatigue severity scale and the modified fatigue impact scale. J Neurological Sci. 2013;331(1–2):102–107.
  • Michielsen HJ, De Vries J, Van Heck GL. Psychometric qualities of a brief self rated fatigue measure: the fatigue assessment scale. J Psychosom Res. 2003;54:345–352.
  • Michielsen HJ, De Vries J, Van Heck G, et al. Examination of the dimensionality of fatigue: the construction of the Fatigue Assessment Scale (FAS). Eur J Psychol Assess. 2004;20:39–48.
  • Penner IK, Raselli C, Stöcklin M, et al. The Fatigue Scale for Motor and Cognitive Functions (FSMC): validation of a new instrument to assess multiple sclerosis-related fatigue. Mult Scler. 2009;15(12):1509–1517.
  • Doward LC, Meads DM, Fisk J, et al. International development of the Unidimensional Fatigue Impact Scale (U-FIS). Value Health. 2010 Jun-Jul;13(4):463–468.
  • Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 1967;6(4):278–296.
  • Flachenecker P, Kumpfel T, Kallmann B, et al. Fatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parameter. Mult Scler. 2002;8:523–526.
  • Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32(no. 1):50–55.
  • Beck AT, Steer RA, Ball R, et al. Comparison of Beck depression inventories-IA and -II in psychiatric outpatients. J Pers Assess. 1996;67(3):588–597.
  • Gershon RC, Rothrock N, Hanrahan R et al. The use of PROMIS and assessment center to deliver patient-reported a outcome measures in clinical research. J Appl Meas. 2010;11(3):304–314.
  • Ameringer S, Elswick RK, Menzies V, et al. Psychometric evaluation of the patient-reported outcomes measurement information system fatigue-short form across diverse populations. Nurs Res. 2016 Jul-Aug;65(4):279–289.
  • Gershon RC, Lai JS, Bode R, et al. Neuro-QOL: quality of life item banks for adults with neurological disorders: item development and calibrations based upon clinical and general population testing. Qual Life Res. 2012 Apr;21(3):475–486.
  • Miller DM, Bethoux F, Victorson D, et al. Validating Neuro-QoL short forms and targeted scales with people who have multiple sclerosis. Mult Scler. 2016 May;22(6):830–841.
  • Vucic S, Burke D, Kiernan MC. Fatigue in multiple sclerosis: mechanisms and management. Clin Neurophysiol. 2010;121:809–817.
  • Asano M, Finlayson ML. Meta-analysis of three different types of fatigue management interventions for people with multiple sclerosis: exercise, education, and medication. Mult Scler Int. 2014;2014:798285.
  • Brañas P, Jordan R, Fry-Smith A, et al. Treatments for fatigue in multiple sclerosis: a rapid and systematic review. Health Technol Assess. 2000;4(27):1–61.
  • Stankoff B, Waubant E, Confavreux C, et al. Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study. Neurology. 2005;64(7):1139–1143.
  • Moller F, Poettgen J, Broemel F, et al. HAGIL (Hamburg Vigil Study): a randomized placebo-controlled double-blind study with modafinil for treatment of fatigue in patients with multiple sclerosis. Mult Scler. 2011;17(8):1002–1009.
  • Peuckmann V, Elsner F, Krumm N, et al. Pharmacological treatments for fatigue associated with palliative care. Cochrane Database Syst Rev. 2010;11:CD006788.
  • Morrow SA, Smerbeck A, Patrick K, et al. Lisdexamfetamine dimesylate improves processing speed and memory in cognitively impaired MS patients: a phase II study. J Neurol. 2013;260:489–497.
  • Kos D, Duportail M, D’Hooghe M, et al. Multidisciplinary fatigue management programme in multiple sclerosis: a randomized clinical trial. Mult Scler. 2007;13:996–1003.
  • Finlayson M, Preissner K, Cho C, et al. Randomized trial of a teleconference-delivered fatigue management program for people with multiple sclerosis. Mult Scler. 2011;17:1130–1140.
  • Briken S, Gold SM, Patra S, et al. Effects of exercise on fitness and cognition in progressive MS: a randomized, controlled pilot trial. Mult Scler. 2014;20:382–390.
  • Dodd KJ, Taylor NF, Shields N, et al. Progressive resistance training did not improve walking but can improve muscle performance, quality of life and fatigue in adults with multiple sclerosis: a randomized controlled trial. Mult Scler. 2011;17:1362–1374.
  • Garcia Jalon EG, Lennon S, Peoples L, et al. Energy conservation for fatigue management in multiple sclerosis: a pilot randomized controlled trial. Clin Rehabil. 2013;27:63–74.
  • Thomas S, Thomas PW, Kersten P, et al. A pragmatic parallel arm multi-centre randomised controlled trial to assess the effectiveness and cost-effectiveness of a group-based fatigue management programme (FACETS) for people with multiple sclerosis. J Neurol Neurosurg Psychiatry. 2013;84:1092–1099.
  • Bogosian A, Chadwick P, Windgassen S, et al. Distress improves after mindfulness training for progressive MS: a pilot randomised trial. Mult Scler. 2015;21:1184–1194.
  • Oken BS, Kishiyama S, Zajdel D, et al. Randomized controlled trial of yoga and exercise in multiple sclerosis. Neurology. 2004;62:2058–2064.
  • Burschka JM, Keune PM, Oy UH, et al. Mindfulness-based interventions in multiple sclerosis: beneficial effects of Tai Chi on balance, coordination, fatigue and depression. BMC Neurol. 2014;14:165.
  • Andreasen AK, Stenager E, Dalgas U. The effect of exercise therapy on fatigue in multiple sclerosis. Mult Scler. 2011;17:1041–1054.
  • Kjølhede T, Vissing K, Dalgas U. Multiple sclerosis and progressive resistance training: a systematic review. Mult Scler. 2012;18:1215–1228.
  • Khan F, Turner-Stokes L, Ng L, et al. Multidisciplinary rehabilitation for adults with multiple sclerosis. Cochrane Database Syst Rev. 2007;2:CD006036.
  • Packer TL, Brink N, Sauriol A. Managing fatigue: a six-week course for energy conservation. Tucson: Therapy Skill Builders; 1996.
  • Plow MA, Finlayson M, Rezac MA. Scoping review of self-management interventions for adults with multiple sclerosis. PM. 2011;R 3:251–262.
  • Knoop H, van Kessel K, Moss-Morris R. Which cognitions and behaviours mediate the positive effect of cognitive behavioural therapy on fatigue in patients with multiple sclerosis? Psychol Med. 2012;42:205–213.
  • Catalan M, De Michiel A, Bratina A, et al. Treatment of fatigue in multiple sclerosis patients: a neurocognitive approach. Rehabil Res Pract. 2011;2011:670537.
  • Rosti-Otajärvi EM, Hämäläinen P. Neuropsychological rehabilitation for multiple sclerosis. Cochrane Database Syst Rev. 2011;11:CD009131.
  • Mori F, Ljoka C, Magni E, et al. Transcranial magnetic stimulation primes the effects of exercise therapy in multiple sclerosis. J Neurol. 2011;258:1281–1287.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.